Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america
- PMID: 23193471
- PMCID: PMC3501796
- DOI: 10.1155/2012/371909
Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america
Abstract
Background. Cardiovascular disease (CVD) is the major predictor of poor prognosis in rheumatoid arthritis (RA) patients. There is an increasing interest to identify "nontraditional" risk factors for this condition. Latin Americans (LA) are considered as a minority subpopulation and ethnically different due to admixture characteristics. To date, there are no systematic reviews of the literature published in LA and the Caribbean about CVD in RA patients. Methods. The systematic literature review was done by two blinded reviewers who independently assessed studies for eligibility. The search was completed through PubMed, LILACS, SciELO, and Virtual Health Library scientific databases. Results. The search retrieved 10,083 potential studies. A total of 16 articles concerning cardiovascular risk factors and measurement of any cardiovascular outcome in LA were included. The prevalence of CVD in LA patients with RA was 35.3%. Non-traditional risk factors associated to CVD in this population were HLA-DRB1 shared epitope alleles, rheumatoid factor, markers of chronic inflammation, long duration of RA, steroids, familial autoimmunity, and thrombogenic factors. Conclusions. There is limited data about CVD and RA in LA. We propose to evaluate cardiovascular risk factors comprehensively in the Latin RA patient and to generate specific public health policies in order to diminish morbi-mortality rates.
Figures


Similar articles
-
Human Leukocyte Antigen Shared Epitope and Inflammation, Cardiovascular Disease, Cancer, and Mortality Among Postmenopausal Women in the Women's Health Initiative Rheumatoid Arthritis Study.Am J Epidemiol. 2017 Jul 15;186(2):245-254. doi: 10.1093/aje/kwx087. Am J Epidemiol. 2017. PMID: 28459968 Free PMC article.
-
Novel risk factors for cardiovascular disease in rheumatoid arthritis.Immunol Res. 2013 Jul;56(2-3):267-86. doi: 10.1007/s12026-013-8398-7. Immunol Res. 2013. PMID: 23584985 Review.
-
HLA-DRB1*07:01 and *08:02 Alleles Confer a Protective Effect Against ACPA-Positive Rheumatoid Arthritis in a Latin American Admixed Population.Biology (Basel). 2020 Dec 14;9(12):467. doi: 10.3390/biology9120467. Biology (Basel). 2020. PMID: 33327594 Free PMC article.
-
Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review.Arthritis Res Ther. 2019 Jan 22;21(1):33. doi: 10.1186/s13075-019-1817-y. Arthritis Res Ther. 2019. PMID: 30670075 Free PMC article.
-
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Rheumatology (Oxford). 2010 Feb;49(2):295-307. doi: 10.1093/rheumatology/kep366. Epub 2009 Nov 27. Rheumatology (Oxford). 2010. PMID: 19946022 Review.
Cited by
-
Rheumatoid arthritis in Colombia: a clinical profile and prevalence from a national registry.Clin Rheumatol. 2021 Sep;40(9):3565-3573. doi: 10.1007/s10067-021-05710-x. Epub 2021 Mar 27. Clin Rheumatol. 2021. PMID: 33772350
-
Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.Clin Rheumatol. 2014 Nov;33(11):1549-55. doi: 10.1007/s10067-014-2570-x. Epub 2014 Mar 20. Clin Rheumatol. 2014. PMID: 24647982
-
Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation.PLoS One. 2014 Jun 5;9(6):e97841. doi: 10.1371/journal.pone.0097841. eCollection 2014. PLoS One. 2014. PMID: 24901254 Free PMC article.
-
Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.Clin Rheumatol. 2017 Jun;36(6):1387-1393. doi: 10.1007/s10067-017-3551-7. Epub 2017 Feb 1. Clin Rheumatol. 2017. PMID: 28150104
-
Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients.Biomark Res. 2015 Sep 4;3:24. doi: 10.1186/s40364-015-0049-9. eCollection 2015. Biomark Res. 2015. PMID: 26346508 Free PMC article.
References
-
- Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. The Lancet. 2010;376(9746):1094–1108. - PubMed
-
- DeMaria AN. Relative risk of cardiovascular events in patients with rheumatoid arthritis. American Journal of Cardiology. 2002;89(6):33D–38D. - PubMed
-
- Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology. 2011;50:2125–2139. - PubMed
-
- Sarzi-Puttini P, Atzeni F, Gerli R, et al. Cardiac involvement in systemic rheumatic diseases: an update. Autoimmunity Reviews. 2010;9(12):849–852. - PubMed
-
- Farzaneh-Far A, Roman MJ. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. International Journal of Clinical Practice. 2005;59(7):823–824. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials